Cooper Companies vs West Pharmaceutical Services
Cooper Companies is the larger business, with $4.09bn of revenue in fiscal 2025 against $3.07bn for West Pharmaceutical Services (1.3 times as much). West Pharmaceutical Services grew faster (6.3% against 5.1%). West Pharmaceutical Services kept more of each dollar of sales as profit: a net margin of 16.1% against 9.2%. West Pharmaceutical Services carries less debt relative to equity (6.4% against 30.4%).
| Latest fiscal year | Cooper CompaniesCOO, 2025 | West Pharmaceutical ServicesWST, 2025 |
|---|---|---|
| Revenue | $4.09bn | $3.07bn |
| Revenue growth | 5.1% | 6.3% |
| Net income | $375m | $494m |
| Operating margin | 16.7% | 19.0% |
| Net margin | 9.2% | 16.1% |
| Return on equity | 4.6% | 16.9% |
| Free cash flow | $434m | $469m |
| Cash | $111m | $791m |
| Total debt | $2.51bn | $203m |
| Debt to equity | 30.4% | 6.4% |
| Dividend per share | — | $0.86 |
| Dividend yield | — | 0.2% |
| Share buybacks | $290m | $134m |
| Employees | — | — |
| Market value | $11.55bn | $28.63bn |
| Price vs our value range | Above our value range | Above our value range |
| Moat score | 73 (Strong) | 77 (Strong) |
| Insider trades, 12 months | 10 buys, 0 sales | 0 buys, 8 sales |